SCOPUS 정보 검색 플랫폼

Cancer

Volumn 76, Issue 10 S, 1995, Pages 2028-2033

Promising new therapies in the treatment of advanced ovarian cancer

(3) Runowicz, Carolyn D a Fields, Abbie L a Goldberg, Gary L a

a ALBERT EINSTEIN COLLEGE OF MEDICINE (United States)

Author keywords

antineoplastic agents; camptothecins; docetaxel; gemcitabine; ovarian cancer; paclitaxel; review

Indexed keywords

ANTINEOPLASTIC AGENT; BUTHIONINE SULFOXIMINE; CAMPTOTHECIN DERIVATIVE; CYCLOSPORIN; DOCETAXEL; GEMCITABINE; IRINOTECAN; PACLITAXEL; TOPOTECAN; TREOSULFAN; VALSPODAR;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; DRUG RESISTANCE; FEMALE; HUMAN; OVARY CANCER; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CLINICAL TRIALS; DEOXYCYTIDINE; DNA TOPOISOMERASES, TYPE I; DRUG RESISTANCE; FEMALE; HUMAN; OVARIAN NEOPLASMS; PACLITAXEL; TOPOTECAN;

EID: 0028860778 PISSN: 0008543X EISSN: 10970142 Source Type: Journal
DOI: 10.1002/1097-0142(19951115)76:10+<2028::AID-CNCR2820761320>3.0.CO;2-M Document Type: Article

Times cited : (28)

References (37)

1
- 0019961380
- Cyclophosphamide plus cisplatin in combination: treatment program for stage III or IV ovarian carcinoma
- (1982) Obstet Gynecol , vol.60 , pp. 481-487
- Decker, DG¹ Fleming, TR² Malkasian, GD³ Webb, MJ⁴ Jefferies, JA⁵ Edmonson, JH⁶

2
- 0027459228
- Taxol in ovarian cancer
- (1993) Cancer , vol.71 , pp. 1591-1596
- Runowicz, CD¹ Wiernik, PH² Einzig, AI³ Goldberg, GL⁴ Horwitz, SB⁵

3
- 0011879579
- Phase II trial of dose intensive versus standard dose cisplatin and cytoxan in advanced ovarian cancer
- (1992) Proc Am Soc Clin Oncol , vol.11 , pp. 226
- McGuire, WP¹ Hoskins, WG² Brady, MF³ Homesley, HD⁴ Clarke‐Pearson, DL⁵

4
- 0024440650
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function
- (1989) J Clin Oncol , vol.7 , pp. 1748-1756
- Calvert, AH¹ Newell, DR² Gumbrell, LA³ O'Reilly, S⁴ Burnell, M⁵ Boxall, FE⁶

5
- 0027717905
- New cytostatic drugs in ovarian cancer
- (1993) Ann Oncol , vol.4 , pp. S63
- Hansen, HH¹ Eisenhauer, EA² Hansen, M³ Neijt, JP⁴ Piccart, MJ⁵ Sessa, C⁶

6
- 0003335131
- An open phase II study to evaluate the efficacy and toxicity of topotecan administered intravenously as 5 daily infusions every 21 days to women with advanced epithelial ovarian carcinoma
- (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 259
- Kudelka, A¹ Edwards, C² Freidman, R³ Wallin, B⁴ Hord, M⁵ Howell, E⁶

7
- 0025899042
- A late phase II study of CPT‐11 in uterine cervical cancer and ovarian cancer: research Groups of CPT‐11 in Gynecologic Cancer
- (1991) Gan to Kagaku Ryoho , vol.18 , pp. 1681-1690
- Takeuchi, S¹ Dobashi, K² Fujimoto, S³ Tanaka, K⁴ Suzuki, M⁵ Terashima, Y⁶

8
- 0027399764
- 2‐difluorodeoxy‐cytidine (gemcitabine)
- (1993) Cancer Treat Rev , vol.19 , pp. 45-55
- Lund, B¹ Kristjansen, PEG² Hansen, HH³

9
- 0004315375
- A phase II evaluation of difluorodeoxycytidine (dFdC) in advanced stage refractory ovarian cancer
- (1991) Proc Am Soc Clin Oncol , vol.10 , pp. 196
- Morgan‐Ihrig, C¹ Lembersky, B² Christopherson, W³ Tarassoff, P⁴

10
- 0007241290
- PT vs. PC (cisplatinum/treosulfan vs. cisplatinum/cyclophosphamide) in advanced ovarian carcinoma: a phase III study
- (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 261
- Breibach, GP¹ Sass, G² Bastert, G³ Neunkirchen, SK⁴

11
- 0345111911
- Treosulfan as an effective secondline chemotherapy in recurrent ovarian cancer
- (1994) Proc Am Soc Clin Oncol , vol.13 , pp. 261
- Meier, W¹ Gropp, M² Hepp, H³

12
- 0027427932
- New cisplatin analogues in development: a review
- (1993) Drugs , vol.46 , pp. 360-377
- Weiss, RB¹ Christian, MC²

13
- 0010271889
- Phase II study of enloplatin for patients with advanced ovarian cancer
- (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 269
- Kudelka, A¹ Edwards, C² Freedman, R³ Siddik, Z⁴ Madden, T⁵ Rastog, R⁶

14
- 0028311404
- The role of intraperitoneal chemotherapy in ovarian cancer
- (1994) Cancer Treat Res , vol.70 , pp. 73-82
- Markman, M¹

15
- 0028107944
- A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer
- (1994) Gynecol Oncol , vol.54 , pp. 338-344
- Kirmani, S¹ Braly, PS² McClay, EF³ Saltzstein, SL⁴ Plaxe, SC⁵ Kim, S⁶

16
- 0023259838
- Dose intensity analysis of chemotherapy regimens in ovarian carcinoma
- (1987) J Clin Oncol , vol.5 , pp. 756-767
- Levin, L¹ Hryniuk, WM²

17
- 0027520058
- Important of multiagent chemotherapy regimens in ovarian carcinoma: dose intensity analysis
- (1993) J Natl Cancer Inst , vol.85 , pp. 1732-1742
- Levin, L¹ Simon, R² Hryniuk, W³

18
- 0026652640
- Randomized study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer
- (1992) Lancet , vol.340 , pp. 329-333
- Kaye, SB¹ Lewis, CR² Paul, J³ Duncan, ID⁴ Gordon, HK⁵ Kitchener, HC⁶

19
- 0343011887
- Conventional versus high dose intensity regimen of cisplatin in advanced ovarian carcinoma: a prospective randomized study
- (1992) Proc Am Soc Clin Oncol , vol.11 , pp. 223
- Bella, M¹ Cocconi, G² Lottici, R³ Leonardi, F⁴ Ceci, G⁵ Passalacqua, R⁶

20
- 0000433786
- Cisplatin dose intensity in advanced ovarian cancer: a randomized study of conventional dose vs. dose‐intense cisplatin chemotherapy
- (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 255
- Colombo, N¹ Pittelli, MR² Parma, G³ Marzola, M⁴ Torri, W⁵ Mangioni, C⁶

21
- 84987200163
- High doses versus standard doses of cisplatin in combination with epidoxorubicin and cyclophosphamide in advanced ovarian cancer patients with bulky residual disease: a randomized trial
- (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 273
- Conte, PF¹ Bruzzone, M² Gadducci, A³ Rubagotti, A⁴ Catsafados, E⁵ Carmino, F⁶

22
- 0027270486
- High‐dose chemotherapy in solid tumors
- (1993) Annals of Oncology , vol.4 , pp. S29
- Antman, KH¹ Souhami, RL²

23
- 0027379862
- Clinical reversal of drug resistance in ovarian cancer
- (1993) Gynecol Oncol , vol.51 , pp. 90-96
- Ozols, RF¹ O'Dwyer, PJ² Hamilton, TC³

24
- 0026561304
- Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results
- (1992) J Natl Cancer Inst , vol.84 , pp. 264-267
- O'Dwyer, PJ¹ Hamilton, TC² Young, RC³ LaCreta, FP⁴ Carp, N⁵ Tew, KD⁶

25
- 0025742877
- Phase I and clinical pharmacologic evaluation of aphidicolin glyconate
- (1991) J Natl Cancer Inst , vol.83 , pp. 1160
- Sessa, C¹ Zucchetti, M² Davoli, E³ Califano, R⁴ Cavalli, F⁵ Feustaci, S⁶

26
- 0026347638
- Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid
- (1991) Cancer Res , vol.51 , pp. 6059-6065
- O'Dwyer, PJ¹ LaCreta, F² Nash, S³ Tinsley, PW⁴ Schilder, R⁵ Clapper, ML⁶

27
- 0025353269
- Cyclosporine A suppresses cisplatin‐induced c‐fos gene expression in ovarian carcinoma cells
- (1990) J Biol Chem , vol.265 , pp. 11285-11288
- Kashaui‐Sabet, M¹ Wang, W² Scanlon, KJ³

28
- 0028057401
- Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer
- (1994) Cancer , vol.73 , pp. 196-199
- Manetta, A¹ Boyle, J² Berman, ML³ DiSaia, PJ⁴ Lentz, S⁵ Liao, SY⁶

29
- 0021852930
- Detection of P‐glycoprotein in multidrug‐resistant cell lines by monoclonal antibodies
- (1985) Nature , vol.316 , pp. 820-823
- Kartner, N¹ Evernden‐Porelle, D² Bradley, G³ Ling, V⁴

30
- 0024506222
- Drug‐resistance in multiple myeloma and non‐Hodgkin's lymphoma: detection of P‐glycoprotein and potential circumvention by addition of verapamil to chemotherapy
- (1989) J Clin Oncol , vol.7 , pp. 415-424
- Dalton, WS¹ Grogan, TM² Meltzer, PS³ Scheper, RJ⁴ Durie, BGM⁵ Taylor, CW⁶

31
- 85005160141
- Epidoxorubicin and Ionidamine in refractory or recurrent epithelial ovarian cancer
- (1994) Proc Am Soc Clin Oncol , vol.13 , pp. 272
- Brunetti, I¹ Giannessi, PG² Dargenio, F³ Gadducci, A⁴ Conte, PF⁵

32
- 0028253311
- Photodynamic therapy for peritoneal carcinomatosis
- (1994) Cancer Treat Res , vol.70 , pp. 83-91
- Tochner, AZ¹

33
- 0027403457
- Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors
- (1993) Int J Rad Oncol Biol Phys , vol.25 , pp. 445-457
- DeLaney, TF¹ Sindelar, WF² Tochner, Z³ Smith, PD⁴ Friauf, WS⁵ Thomas, G⁶

34
- 0001104386
- Phase II study of taxotere in ovarian cancer. EORTC: Clinical Screening Group
- (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 256
- Aapro, M¹ Pujade‐Lauraine, E² Lhomme, C³ Lentz, MA⁴ LeBail, N⁵ Fumoleau, P⁶

35
- 0013474588
- Taxotere (RP 56976, NSC 628503): an active new drug for the treatment of advanced ovarian cancer
- (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 258
- Piccart, MJ¹ Gore, M² tenBokkel Huinink, W³ Van Oosterom, A⁴ Verweij, J⁵ Kaye, S⁶

36
- 0003335131
- A phase II trial of taxotere (RP 56976) in ovarian cancer patients refractory to cisplatin/carboplatin therapy
- (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 259
- Kavanagh, JJ¹ Kudelka, AP² Freedman, RS³ Edwards, CL⁴ Pazdur, R⁵ Bellet, R⁶

37
- 0344647023
- Phase II study of docetaxel (taxotere) in advanced platinum‐refractory ovarian cancer
- (1994) Proc Am Soc Clin Oncol , vol.13 , pp. 260
- Frances, P¹ Hakes, T² Schneider, J³ Spriggs, D⁴ Fennelly, D⁵ Hann, L⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.